Published in Vaccine on May 23, 2015
Questions regarding the safety and duration of immunity following live yellow fever vaccination. Expert Rev Vaccines (2016) 0.80
Vaccination and anaphylaxis: a forensic perspective. Croat Med J (2017) 0.75
Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med (1995) 5.73
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA (2009) 5.58
Intussusception among infants given an oral rotavirus vaccine. N Engl J Med (2001) 5.33
Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol (1979) 3.36
Addressing the vaccine confidence gap. Lancet (2011) 3.24
Impact of vaccines universally recommended for children--United States, 1990-1998. MMWR Morb Mortal Wkly Rep (1999) 2.68
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep (2003) 2.53
Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med (2014) 2.41
Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2010) 2.00
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2010) 1.99
Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain (2007) 1.87
Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet (2013) 1.82
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J (2004) 1.76
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.67
Varicella vaccination in a child with acute lymphoblastic leukaemia. Lancet (2007) 1.61
Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med (2014) 1.59
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013. Vaccine (2014) 1.46
Epidemiology of vaccine hesitancy in the United States. Hum Vaccin Immunother (2013) 1.45
Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis (2006) 1.41
Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine (2009) 1.40
Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics (2003) 1.36
ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile. Drug Des Devel Ther (2010) 1.27
Measles - United States, January 4-April 2, 2015. MMWR Morb Mortal Wkly Rep (2015) 1.23
Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep (2006) 1.14
Fatal varicella due to the vaccine-strain varicella-zoster virus. Hum Vaccin Immunother (2013) 1.11
Suspension of rotavirus vaccine after reports of intussusception--United States, 1999. MMWR Morb Mortal Wkly Rep (2004) 1.07
Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA (2012) 1.05
Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis (1999) 1.03
Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993. MMWR Morb Mortal Wkly Rep (1996) 1.03
Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis (2014) 1.02
The Cutter incident, 50 years later. N Engl J Med (2005) 1.00
Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system. Pediatrics (2001) 0.92
Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. J Infect Dis (2014) 0.91
Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012. Pediatrics (2013) 0.90
Guillain-Barré syndrome incidence in a large United States cohort (2000-2009). Neuroepidemiology (2012) 0.90
Food and Drug Administration regulation and evaluation of vaccines. Pediatrics (2011) 0.88
Potential intussusception risk versus benefits of rotavirus vaccination in the United States. Pediatr Infect Dis J (2013) 0.87
Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic. Am J Public Health (2014) 0.86
The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997. Pharmacoepidemiol Drug Saf (2001) 0.83
Syncope after immunization. Arch Pediatr Adolesc Med (1997) 0.83
Mortality rates and cause-of-death patterns in a vaccinated population. Am J Prev Med (2013) 0.82
Reported adverse events in young women following quadrivalent human papillomavirus vaccination. J Womens Health (Larchmt) (2012) 0.82
Trends in intussusception-associated deaths among US infants from 1979-2007. J Pediatr (2011) 0.80
Clinical guidance for smallpox vaccine use in a postevent vaccination program. MMWR Recomm Rep (2015) 0.79
Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013. J Pediatr (2015) 0.77
Analysis of anaphylaxis cases after vaccination: 10-year review from the National Vaccine Injury Compensation Program. Ann Allergy Asthma Immunol (2011) 0.77
Fatal syncope-related fall after immunization. Arch Pediatr Adolesc Med (2005) 0.77
Vaccines in the pipeline: the path from development to use in the United States. Pediatr Ann (2013) 0.76
Post-Licensure Surveillance of Trivalent Live-Attenuated Influenza Vaccine in Children Aged 2-18 Years, Vaccine Adverse Event Reporting System, United States, July 2005-June 2012. J Pediatric Infect Dis Soc (2014) 0.76